PACB vs TECH
Pacific Biosciences of California (PACB) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
PACB currently screens at market cap $387.1M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the PACB and TECH stock pages for the full models.
Not investment advice.